Skip to main content
SpringerLink
Log in

Biology and reversal of aerodigestive tract carcinogenesis

  • Chapter
Head and Neck Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 74))

Abstract

Squamous cell carcinoma of the upper aerodigestive tract is a cosmetically, functionally, and economically devastating class of diseases yet to come under control with standard approaches to prevention, early detection, or therapy [1,2]. Three principle modalities are currently used to control this disease: tobacco/alcohol cessation programs, surgery and radiotherapy for early and local-regional advanced disease, and chemotherapy in advanced, recurrent, and metastatic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 328:184–194, 1993.

    PubMed  CAS  Google Scholar 

  2. Wolf G, Lippman SM, Laramore G, Hong WK. Head and neck cancer. In: JF Holland, E Frei, RC Bast Jr, et al. eds. Cancer Medicine, 3rd ed. Philadelphia: Lea & Febiger, 1211–1275, 1993.

    Google Scholar 

  3. Centers for Disease Control. Cigarette smoking among adults — United States, 1991. MMWR 42:230–233, 1993.

    Google Scholar 

  4. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous-cell carcinoma: The overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17:691–694, 1989.

    PubMed  CAS  Google Scholar 

  5. Lippman SM, Hong WK. Not yet standard: Retinoids versus second primary tumors. J Clin Oncol 1204–1207, 1993.

    Google Scholar 

  6. Sporn MB, Dunlop NM, Newton DL, Smith JB. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35:1332–1338, 1976.

    PubMed  CAS  Google Scholar 

  7. Boone CW, Kelloff GJ, Malone WE. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review. Cancer Res 50:2–9, 1990.

    PubMed  CAS  Google Scholar 

  8. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 12:851–873, 1994.

    PubMed  CAS  Google Scholar 

  9. Toth BB, Martin J, Lippman SM, Hong WK. Chemoprevention as a form of cancer control. J Am Dent Assoc 124:243–246, 1993.

    PubMed  CAS  Google Scholar 

  10. Lippman SM, Spitz MR. Intervention in the premalignant process. Cancer Bull 43:473–474, 1992.

    Google Scholar 

  11. Benner SE, Lippman SM, Hong WK. Retinoid chemoprevention of second primary tumors. Semin Hematol 31 (Suppl 5):26–30, 1994.

    PubMed  CAS  Google Scholar 

  12. Hong WK, Doos WG. Chemoprevention of head and neck cancer. Otolaryngol Clin North Am 18:543–549, 1985.

    PubMed  CAS  Google Scholar 

  13. Boone CW, Kelloff GJ, Steele VE. Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Cancer Res 52:1651–1659, 1991.

    Google Scholar 

  14. Hong WK, Lippman SM, Wolf GT. Recent advances in head and neck cancer — larynx preservation and cancer chemoprevention: The Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 53:1–8, 1993.

    Google Scholar 

  15. Hirayama T. Diet and cancer. Nutr Cancer 1:67–81, 1979.

    Google Scholar 

  16. Shekelle RB, Lepper M, Liu S, Maliza C, Raynor WJ Jr, Rossof AH. Dietary vitamin A and risk of cancer in the Western Electric study. Lancet 2:1185–1190, 1981.

    PubMed  CAS  Google Scholar 

  17. Kvale G, Bjelke E, Gart JJ. Dietary habits and lung cancer risk. Int J Cancer 31:397–405, 1983.

    PubMed  CAS  Google Scholar 

  18. Wang L, Hammond EC. Lung cancer, fruit, green salad, and vitamin pills. Chin Med J (Engl) 98:206–210, 1985.

    CAS  Google Scholar 

  19. Krombout D. Essental micronutrients in relation to carcinogenesis. Am J Clin Nutr 45:1361–1367, 1987.

    Google Scholar 

  20. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Vitamin A, ß-carotene, and the risk of cancer: A prospective study. J Natl Cancer Inst 79:443–448, 1987.

    PubMed  CAS  Google Scholar 

  21. Menkes MS, Constock GW, Vuilleumier JP, et al. Serum ß-carotene, vitamins A and E, selenium and the risk of lung cancer. N Engl J Med 315:1250–1254, 1986.

    PubMed  CAS  Google Scholar 

  22. Willett WC, Polk BF, Underwood BA, et al. Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med 310:430–434, 1989.

    Google Scholar 

  23. Peto R, Doll R, Buckley JD, et al. Can dietary ß-carotene materially reduce human cancer rates? Nature 290:201–208, 1981.

    PubMed  CAS  Google Scholar 

  24. Farber E. The multistep nature of cancer development. Cancer Res 44:4217–4223, 1984.

    PubMed  CAS  Google Scholar 

  25. Slaga TJ, Jimenez Conti IB. An animal model for oral cancer. J Natl Canc Inst Monogr 13:55–61, 1992.

    Google Scholar 

  26. Santis H, Shklar G, Chauncey HH. Histochemistry of experimentally induced leukoplakia and carcinoma of the hamster buccal pouch. Oral Surg Oral Med Oral Pathol 17:84–95, 1964.

    PubMed  CAS  Google Scholar 

  27. Shklar G, Schwartz J, Grau D, et al. Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. Oral Surg 50:45–52, 1980.

    PubMed  CAS  Google Scholar 

  28. Lee JS, Kim SY, Hong WK, et al. Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. J Natl Cancer Inst 85:1951–1954, 1993.

    PubMed  CAS  Google Scholar 

  29. Shklar G. Oral mucosal carcinogenesis in hamster: Inhibition by vitamin E. J Natl Cancer Inst 68:791–797, 1982.

    PubMed  CAS  Google Scholar 

  30. Moon RC, Rao KVN, Detrisac CJ, Kelloff GJ. Animal models for chemoprevention of respiratory cancer. J Natl Cancer Inst 13:45–49, 1992.

    Google Scholar 

  31. Sporn MB. Carcinogenesis and cancer: Different perspectives on the same disease. Cancer Res 51:6215–6218, 1991.

    PubMed  CAS  Google Scholar 

  32. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: Clinical implications of multicentric origin. Cancer 6:963–968, 1953.

    PubMed  CAS  Google Scholar 

  33. Lee JS, Lippman SM, Hong WK, et al. Determination of biomarkers for intermediate end points in chemoprevention. Cancer Res 52(Suppl):S2707–S2710, 1992.

    Google Scholar 

  34. Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. Biomarkers as intermediate endpoints in chemoprevention trials. J Natl Cancer Inst 82:555–560, 1990.

    PubMed  CAS  Google Scholar 

  35. Voravud N, Shin DM, Ro JY, et al. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res 53:2874–2883, 1993.

    PubMed  CAS  Google Scholar 

  36. Shin DM, Voravud N, Ro JY, et al. Sequential increase of proliferating cell nuclear antigen expression in head and neck tumorigenesis: A potential biomarker. J Natl Cancer Inst 85:971–978, 1993.

    PubMed  CAS  Google Scholar 

  37. Nees M, Homann N, Discher H, Andl T, Enders C, Herold C, Schuhmann A, Bosch FX. Expression of mutated p53 tumor-distant epithelia of head and neck cancer patients: Molecular basis for the development of multiple tumors. Cancer 53:4189–4196, 1993.

    CAS  Google Scholar 

  38. Sozzi G, Miozzo M, Tagliabue E, et al. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res 51:400–404, 1991.

    PubMed  CAS  Google Scholar 

  39. Sozzi G, Miozzi M, Donglhi R, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52:6079–6082, 1992.

    PubMed  CAS  Google Scholar 

  40. Girod SC, Fischer U, Rollins BJ. p53 as a prognostic factor in neoplastic and preneoplastic lesions of the oral mucosa. Proc Am Assoc Cancer Res 34:103, 1993.

    Google Scholar 

  41. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science 253:49–53, 1991.

    PubMed  CAS  Google Scholar 

  42. Vogelstein B, Fearon ER, Hamilton SR. Genetic alterations during colorectal tumor development. N Engl J Med 319:525–532, 1988.

    PubMed  CAS  Google Scholar 

  43. Takahashi T, Nau MM, Chiba I, et al. p53: A frequent target for genetic abnormalities in lung cancer. Science 246:491–494, 1989.

    PubMed  CAS  Google Scholar 

  44. Iggo R, Gatter K, Bartek J, et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675–679, 1990.

    PubMed  CAS  Google Scholar 

  45. Vahakangas KH, Samet JM, Metcalf RA, et al. Mutations of p53 and ras genes in rado-associated lung cancer from uranium miners. Lancet 339:576–580, 1992.

    PubMed  CAS  Google Scholar 

  46. Branchman DG, Graves D, Vokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 52:4832–4836, 1992.

    Google Scholar 

  47. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 6:1785–1789, 1991.

    PubMed  CAS  Google Scholar 

  48. Zhou DJ, Casey G, Cline MJ. Amplification of human int-2 in breast cancers and squamous carcinomas. Oncogene 2:279–282, 1988.

    PubMed  CAS  Google Scholar 

  49. Somers KD, Cartwright SL, Schechter GL. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 5:915–920, 1990.

    PubMed  CAS  Google Scholar 

  50. Merritt WD, Weissler MC, Turk BF, Gilmer TM. Oncogene amplification in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 116:1394–1398, 1990.

    PubMed  CAS  Google Scholar 

  51. Berenson JR, Yang J, Mickel RA. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene 4:1111–1116, 1989.

    PubMed  CAS  Google Scholar 

  52. Cowan JM, Beckett MA, Ahmed-Swan S, Weichselbaum RR. Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J Natl Cancer Inst 84:793–797, 1992.

    PubMed  CAS  Google Scholar 

  53. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res 52:5997–6000, 1992.

    PubMed  CAS  Google Scholar 

  54. Chung KY, Mukhopadhyay T, Kim J, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodiges-tive tract. Cancer Res 53:1676–1683, 1993.

    PubMed  CAS  Google Scholar 

  55. Hennekens CH. Issues in the design and conduct of clinical trials. J Natl Cancer Inst 73:1473–1476, 1984.

    PubMed  CAS  Google Scholar 

  56. Buring JE, Hennekens CH. The Women’s Health Study: Summary of the study design. J Myocard Ischemia 4:27–29, 1992.

    Google Scholar 

  57. Boring CC, Squires RS, Tong T. Cancer statistics, 1993. Ca Cancer J Clin 43:7–26, 1993.

    PubMed  CAS  Google Scholar 

  58. Strong MS, Incze J, Vaughan CW. Field cancerization in the aerodigestive tract — Its etiology, manifestation, and significance. J Otolaryngol 13:1–6, 1984.

    PubMed  CAS  Google Scholar 

  59. Kramer IR, Luca RB, Pindorg JJ, et al. Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518–539.

    Google Scholar 

  60. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation a follow-up study of 257 patients. Cancer 53:563–568, 1984.

    PubMed  Google Scholar 

  61. Burquot JE, Weiland LH, Kurland LT. Leukoplakia and carcinoma in situ synchronously associated with invasive oral/oropharyngeal carcinoma in Rochester, Minn., 1935–1984. Oral Surg Oral Med Oral Pathol 65:199–207, 1988.

    Google Scholar 

  62. Banoczy J, Cisba A. Comparative study of the clinical picture and histopathologic structure of oral leukoplakia. Cancer 29:1230–1234, 1972.

    PubMed  CAS  Google Scholar 

  63. Lippman SM, Kessler JF, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 71:391–405, 493–515, 1987.

    PubMed  CAS  Google Scholar 

  64. Smith MA, Parkinson DR, Cheson BD, Friedman MA. Retinoids in cancer therapy. J Clin Oncol 10:839–864, 1992.

    PubMed  CAS  Google Scholar 

  65. Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids: Biology, Chemistry and Medicine, 2nd ed. New York: Raven Press, 1994.

    Google Scholar 

  66. Evans R. The steroid and thyroid hormone receptor super family. Science 240:889–895, 1988.

    PubMed  CAS  Google Scholar 

  67. Silverman S, Renstrup G, Pindborg JJ. Studies in oral leukoplakia. Acta Odontol Scand 21:271–292, 1963.

    PubMed  Google Scholar 

  68. Silverman S, Eisenberg E, Renstrup G. A study of the effects of high doses of vitamin A on oral leukoplakia (hyperkeratosis), including toxicity, liver function and skeletal metabolism. J Oral Ther Pharmacol 2:9–23, 1965.

    CAS  Google Scholar 

  69. Wolf K. Zur vitamin A behandlung der leukoplakien. Arch Klin Exp Derm 206:495–498, 1957.

    Google Scholar 

  70. Raque CJ, Biondo RV, Keeran MG, et al. Snuff dippers kekratosis (snuff-induced leukoplakia). South Med J 68:565–568, 1975.

    PubMed  CAS  Google Scholar 

  71. Koch HF. Effet of retinoids on precancerous lesions of oral mucosa. In: CE Orfanos, O Braun-Falco, EM Farbert, et al. (eds.) Retinoids: Advances in Basic Reasearch and Therapy. Berlin: Springer-Verlag, 1981, pp 307–312.

    Google Scholar 

  72. Shah JP, Strong Ew, DeCosse JJ, et al. Effect of retinoids on oral leukoplakia. Am J Surg 146:466–470, 1983.

    PubMed  CAS  Google Scholar 

  73. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501–1505, 1986.

    PubMed  CAS  Google Scholar 

  74. Han J, Lu Y, Sun Z, et al. Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent. In Vivo 4:153–160, 1990.

    PubMed  Google Scholar 

  75. Stich HF, Hornby AP, Mathew B, et al. Response of oral leukoplakia to the administration of vitamin A. Cancer Lett 40:93–101, 1988.

    PubMed  CAS  Google Scholar 

  76. Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 328:15–20, 1993.

    PubMed  CAS  Google Scholar 

  77. Chiesa F, Tradati N, Morazza M, et al. Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid ferentinide (4-HPR). Preliminary results. Oral Oncol Eur J Cancer 28B:97–102, 1992.

    CAS  Google Scholar 

  78. Xu JM, Plezia PM, Alberts DS, et al. Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta carotene in humans and mice. J Natl Cancer Inst 84:1559–1565, 1992.

    PubMed  CAS  Google Scholar 

  79. Stich HF, Rosin MP, Hornby AP, et al. Remission of oral leukoplakia and micronuclei in tobacco/betel quid chewers treated with beta carotene and with beta carotene plus vitamin A. Int J Cancer 42:195–199, 1988.

    PubMed  CAS  Google Scholar 

  80. Garewal HS, Meyskens FL, Killen D, et al. Responses of oral leukoplakia to ß-carotene. J Clin Oncol 8:1715–1720, 1990.

    PubMed  CAS  Google Scholar 

  81. Toma S, Albanese E, DeLorenzi M, et al. ß-carotene in the treatment of oral leukoplakia. Proc Am Soc Clin Oncol 9:179, 1990.

    Google Scholar 

  82. Benner SE, Winn RJ, Lippman SM, et al. Regression of oral leukoplakia with alpha-tocopherol: A Community Clinical Oncology Progrem (CCOP) chemoprevention study. J Natl Cancer Inst 85:44–47, 1993.

    PubMed  CAS  Google Scholar 

  83. Benner SE, Wargovich MJ, Lippman SM, et al. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia. Cancer Epidemiol Biomarkers Prevent 3:73–76, 1994.

    CAS  Google Scholar 

  84. Lippman SM, Hong WK. Differentiation therapy for head and neck cancer. In: G Snow, JR Clark, eds. Multimodality Therapy for Head and Neck Cancer. Verlag Press, 1992, pp 160–181.

    Google Scholar 

  85. Omenn GS, Goodman GE, Thornquist MD, et al. The carotene and retinol efficacy trial (CARET) to prevent lung cancer in high-risk populations: Pilot study with asbestos-exposed workers Cancer Epidemiol Biomarkers Prevent 2:2381–387, 1993.

    Google Scholar 

  86. Heimburger DC, Alexander B, Birch R, et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 259:1525–1530, 1988.

    PubMed  CAS  Google Scholar 

  87. van Poppel G, Kok FJ, Hermus RJJ. Beta-carotene supplementation in smokers reduces the frequency of micronuclei in sputum. Br J Cancer 66:1164–1168, 1992.

    PubMed  Google Scholar 

  88. Gouveia J, Mathe G, Hercend T, et al. Degree of bronchial metaplasia in heavy smokers and its regression after treatment with a retinoid. Lancet 1:710–712, 1983.

    Google Scholar 

  89. Lee JS, Lippman SM, Benner SE, et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 12:937–945, 1994.

    PubMed  CAS  Google Scholar 

  90. Arnold AM, Browman GP, Levine MN, et al. The effect of the synthetic retinoid etretinate on sputum cytology: Results from a randomised trial. Br J Cancer 65:737–743, 1992.

    PubMed  CAS  Google Scholar 

  91. Rosin MP, Dunn BP, Stich HF. Use of intermediate end points in quanitating the response of precancerous lesions to chemopreventive agents. Cana J Physiol Pharmacol 65:483–487, 1987.

    CAS  Google Scholar 

  92. Stich HF, Rosin MP, Vallejera MO. Reduction with vitamin A and beta-cartene administration of proportion of micronucleated buccal mucosal cells in Asian betel nut and tobacco chewers. Lancet 1:1204–1206, 1984.

    PubMed  CAS  Google Scholar 

  93. Stich HF, Hornby AP, Dunn BP. A pilot ß-carotene invervention trial with Inuits using smokeless tobacco. Int J Cancer 36:321–327, 1985.

    PubMed  CAS  Google Scholar 

  94. Schatzkin A, Freedman LS, Schiffman MH, et al. Validation of intermediate end points in cancer research. J Natl Cancer Inst 82:1746–1753, 1990.

    PubMed  CAS  Google Scholar 

  95. Warren S, Gates O. Multiple primary malignant tumors: A survey of the literature and statistical study. Am J Cancer 51:1358–1403, 1932.

    Google Scholar 

  96. Licciardillo JT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: Second cancer of the head and neck, esophagus and lung. Int J Radiat Oncol Biol Phys 17:467–476, 1989.

    Google Scholar 

  97. Ihde DC, Tucker MA. Secondary primary malignancies in small-cell lung cancer: A major consequence of modest success. J Clin Oncol 10:1511–1513, 1992.

    PubMed  CAS  Google Scholar 

  98. Christensen P, Joergensen K, Munk J, Oesterlind A. Hyperfrequency of pulmonary cancer in a population of 415 patients treated for laryngeal cancer. Laryngoscope 97:612–614, 1987.

    PubMed  CAS  Google Scholar 

  99. Tepperman BS, Fitzpatrick PJ. Second respiratory and upper digestive tract cancers after oral cancer. Lancet 2:547–549, 1981.

    PubMed  CAS  Google Scholar 

  100. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications for chemoprevention based on the RTOG experience. Int J Radiat Oncol Biol Phys 17:449–465, 1989.

    PubMed  CAS  Google Scholar 

  101. McDonald S, Haie C, Rubin P, Nelson D, Divers LD. Second malignant tumors of laryngeal carcinoma: Diagnosis, treatment, and prevention. Int J Radiat Oncol Biol Phys 17:457–65, 1989.

    PubMed  CAS  Google Scholar 

  102. Vikram B. Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 110:564–565, 1984.

    PubMed  CAS  Google Scholar 

  103. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323:795–801, 1990.

    PubMed  CAS  Google Scholar 

  104. Benner SE, Pajak TF, Lippman, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck: Long-term follow-up. J Natl Cancer Inst 86:140–141, 1994.

    PubMed  CAS  Google Scholar 

  105. Pastorino U, Infante M, Mioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 11:1216–1222, 1993.

    PubMed  CAS  Google Scholar 

  106. Lippman SM, Hong WK. Retinoid chemoprevention of upper aerodigestive tract carcinogenesis. In: VT DeVita, S Hellman, SA Rosenberg, eds. Important Advances in Oncology. Philadelphia: JB Lippincott, 1992, pp 93–109.

    Google Scholar 

  107. Moore C. Smoking and cancer of the mouth, pharynx, and larynx. JAMA 191:107–110, 1965.

    Google Scholar 

  108. Moore C. Cigarette smoking in cancer of the mouth, pharynx, and larynx — A continuing study. JAMA 218:553–558, 1971.

    PubMed  CAS  Google Scholar 

  109. Silverman S, Griffith M. Smoking characteristics of patients with oral carcinoma and the risk for second oral primary carcinoma. J Am Dental Assoc 85:637–640, 1972.

    Google Scholar 

  110. Silverman S, Gorsky M, Greenspan D. Tobacco usage in patients with head and neck carcinomas: A follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dental Assoc 106:33–35, 1983.

    Google Scholar 

  111. Wynder EL, Dodo H, Bloch DA, Gantt RC, Moore OS. Epidemiologic investigation of multiple cancer in the upper alimentary and respiratory tracts. Cancer 24:730–739, 1969.

    PubMed  CAS  Google Scholar 

  112. Hellquist H, Lundgren J, Olofosson J. Hyperplasia, keratosis, dysplasia, and carcinoma in situ of the vocal cords. Clin Otolaryngol 7:11–27, 1982.

    PubMed  CAS  Google Scholar 

  113. Gillis TM, Incze J, Strong MS, Vaughan CW, Simpson Gy. Natural history and management of keratosis, atypia, carcinoma in situ and microinvasive cancer of the larynx. Am J Surg 146:512–519, 1983.

    PubMed  CAS  Google Scholar 

  114. Castigliano SC. Influence of continous smoking on the incidence of second primary cancers involving mouth, pharynx and larynx. J Am Dent Assoc 77:580–585, 1968.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Scott M. Lippman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary L. Clayman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin H. Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Steven E. Benner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Waun Ki Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. M. D. Anderson Cancer Center, The University of Texas, Houston, Texas, USA

    Waun Ki Hong M.D.  & Randal S. Weber M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lippman, S.M., Clayman, G.L., Huber, M.H., Benner, S.E., Hong, W.K. (1995). Biology and reversal of aerodigestive tract carcinogenesis. In: Hong, W.K., Weber, R.S. (eds) Head and Neck Cancer. Cancer Treatment and Research, vol 74. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2023-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2023-8_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5837-4

  • Online ISBN: 978-1-4615-2023-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation